Dynavax Technologies - Stock Price History | DVAX
Historical daily share price chart and data for Dynavax Technologies since 2021 adjusted for splits. The latest closing stock price for Dynavax Technologies as of October 27, 2021 is 19.70.
- The all-time high Dynavax Technologies stock closing price was 98.50 on December 11, 2006.
- The Dynavax Technologies 52-week high stock price is 20.96, which is 6.4% above the current share price.
- The Dynavax Technologies 52-week low stock price is 3.58, which is 81.8% below the current share price.
- The average Dynavax Technologies stock price for the last 52 weeks is 9.83.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Dynavax Technologies Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2020 |
5.3443 |
5.4700 |
11.7000 |
2.2700 |
4.4500 |
-22.20% |
| 2019 |
6.1580 |
9.4500 |
12.0900 |
2.6900 |
5.7200 |
-37.49% |
| 2018 |
14.7785 |
18.8000 |
20.7500 |
8.1400 |
9.1500 |
-51.07% |
| 2017 |
11.8018 |
4.0500 |
24.0750 |
3.8000 |
18.7000 |
373.42% |
| 2016 |
14.7131 |
23.1500 |
29.7000 |
3.9000 |
3.9500 |
-83.65% |
| 2015 |
23.6379 |
17.4100 |
31.6800 |
16.0000 |
24.1600 |
43.30% |
| 2014 |
15.7874 |
19.9000 |
20.7000 |
13.0000 |
16.8600 |
-13.98% |
| 2013 |
18.6199 |
29.2000 |
33.3000 |
10.1000 |
19.6000 |
-31.23% |
| 2012 |
40.2482 |
32.8000 |
52.6000 |
24.4000 |
28.5000 |
-14.16% |
| 2011 |
27.1563 |
30.9000 |
35.3000 |
18.2000 |
33.2000 |
3.75% |
| 2010 |
18.1281 |
14.4000 |
32.0000 |
12.7000 |
32.0000 |
125.35% |
| 2009 |
12.5715 |
7.8990 |
25.5000 |
5.1000 |
14.2000 |
69.05% |
| 2008 |
22.2934 |
52.5000 |
65.5000 |
1.5100 |
8.4000 |
-83.56% |
| 2007 |
48.6636 |
84.7000 |
87.9000 |
36.7000 |
51.1000 |
-44.34% |
| 2006 |
55.9188 |
42.9000 |
98.5000 |
36.4000 |
91.8000 |
118.05% |
| 2005 |
53.6628 |
77.9000 |
79.9000 |
35.9000 |
42.1000 |
-47.38% |
| 2004 |
66.9763 |
94.0000 |
94.0000 |
41.8000 |
80.0000 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.201B |
$0.047B |
|
Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.
|
